UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Volume Status and Diuretic Therapy in Systolic Heart Failure and the Detection of Early Abnormalities in Renal and Tubular Function

Journal of the American College of Cardiology, 2011-05, Vol.57 (22), p.2233-2241

2011

Volltextzugriff (PDF)

Screening for atrial fibrillation: one size does not fit all

BMJ (Online), 2019-03, Vol.364, p.l1396

MacFadyen, Robert J

2019

Volltextzugriff (PDF)

Impact of pre-admission oral anticoagulation on ischaemic stroke volume, lesion pattern, and frequency of intracranial arterial occlusion in patients with atrial fibrillation: simplicity to complexity and refining the need to try harder?

Europace (London, England), 2018-11, Vol.20 (11), p.1711-1713

MacFadyen, Robert J

2018

Volltextzugriff (PDF)

Ambulatory blood pressure monitoring in heart failure: a systematic review

European journal of heart failure, 2005-03, Vol.7 (2), p.149-156

2005

Volltextzugriff (PDF)

Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation

Platelets (Edinburgh), 2005-09, Vol.16 (6), p.368-371

2005

Volltextzugriff (PDF)

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in Hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

American journal of hypertension, 2004-09, Vol.17 (9), p.764-769

2004

Volltextzugriff (PDF)

Plasma Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-2, and CD40 Ligand Levels in Patients With Stable Coronary Artery Disease

The American journal of cardiology, 2005-08, Vol.96 (3), p.339-345

2005

Volltextzugriff (PDF)

Prevention of cardiovascular disease guided by total risk estimations − challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy

European journal of preventive cardiology, 2012-12, Vol.19 (6), p.1454-1464

2012

Volltextzugriff (PDF)

Furosemide responsiveness, non‐adherence and resistance during the chronic treatment of heart failure: a longitudinal study

British journal of clinical pharmacology, 2004-05, Vol.57 (5), p.622-631

2004

Volltextzugriff (PDF)

Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance

Current medicinal chemistry, 2005-01, Vol.12 (8), p.917-925

2005

Volltextzugriff (PDF)

Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease

Thrombosis and haemostasis, 2006-01, Vol.95 (1), p.202-204

2006

Volltextzugriff (PDF)

Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques

Fundamental & clinical pharmacology, 2012-04, Vol.26 (2), p.163-174

2012

Volltextzugriff (PDF)

Performing Repeated Noninvasive Bedside Measures of Volume Response to Intravenous Furosemide in Acute Pulmonary Edema: A Feasibility Assessment

Cardiovascular therapeutics, 2009, Vol.27 (2), p.89-95

2009

Volltextzugriff (PDF)

Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine?

Current opinion in pharmacology, 2007-04, Vol.7 (2), p.171-178

MacFadyen, Robert J

2007

Volltextzugriff (PDF)

Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure

Circulation (New York, N.Y.), 1996-06, Vol.93 (11), p.2037-2042

1996

Volltextzugriff (PDF)

Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2

Thrombosis research, 2005, Vol.115 (3), p.205-210

2005

Volltextzugriff (PDF)

Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?

European journal of heart failure, 2010-07, Vol.12 (7), p.649-652

2010

Volltextzugriff (PDF)

Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension: Relationship to tissue Doppler indices of diastolic relaxation

American journal of hypertension, 2004-09, Vol.17 (9), p.770-774

2004

Volltextzugriff (PDF)

Multiple microvessels extending from the coronary arteries to the left ventricle in a middle aged female presenting with ischaemic chest pain: a case report

Journal of medical case reports, 2007-12, Vol.1 (1), p.177-177, Article 177

2007

Volltextzugriff (PDF)

Extracellular matrix biology: a new frontier in linking the pathology and therapy of hypertension?

Journal of hypertension, 2003-12, Vol.21 (12), p.2211-2218

2003

Volltextzugriff (PDF)

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and-2 in type 2 diabetes: Effect of 1 year's cardiovascular risk reduction therapy

Diabetes care, 2004-08, Vol.27 (8), p.2049-2051

2004

Volltextzugriff (PDF)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 and -2 in Type 2 Diabetes

Diabetes care, 2004-08, Vol.27 (8), p.2049-2051

2004

Volltextzugriff (PDF)

Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension

American journal of hypertension, 2005-03, Vol.18 (3), p.325-329

2005

Volltextzugriff (PDF)

Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?

European heart journal, 2007-04, Vol.28 (8), p.929-940

2007

Volltextzugriff (PDF)

Perception of symptoms in hypertensive patients and the relevance to the application of anti- hypertensive drug therapy

Current pharmaceutical design, 2006-05, Vol.12 (13), p.1557-1565

2006

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(192)

Publikationsform

Artikel
(218)
Buchkapitel
(10)
Reviews
(2)

Sprache

Englisch
(230)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Volume Status and Diuretic Therapy in Systolic Heart Failure and the Detection of Early Abnormalities in Renal and Tubular Function

Screening for atrial fibrillation: one size does not fit all

Impact of pre-admission oral anticoagulation on ischaemic stroke volume, lesion pattern, and frequency of intracranial arterial occlusion in patients with atrial fibrillation: simplicity to complexity and refining the need to try harder?

Ambulatory blood pressure monitoring in heart failure: a systematic review

Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in Hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Plasma Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-2, and CD40 Ligand Levels in Patients With Stable Coronary Artery Disease

Prevention of cardiovascular disease guided by total risk estimations − challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy

Furosemide responsiveness, non‐adherence and resistance during the chronic treatment of heart failure: a longitudinal study

Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance

Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease

Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques

Performing Repeated Noninvasive Bedside Measures of Volume Response to Intravenous Furosemide in Acute Pulmonary Edema: A Feasibility Assessment

Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine?

Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure

Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2

Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?

Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension: Relationship to tissue Doppler indices of diastolic relaxation

Multiple microvessels extending from the coronary arteries to the left ventricle in a middle aged female presenting with ischaemic chest pain: a case report

Extracellular matrix biology: a new frontier in linking the pathology and therapy of hypertension?

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and-2 in type 2 diabetes: Effect of 1 year's cardiovascular risk reduction therapy

Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 and -2 in Type 2 Diabetes

Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension

Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?

Perception of symptoms in hypertensive patients and the relevance to the application of anti- hypertensive drug therapy

Suchergebnisse filtern